KARLSHAMN, Sweden, May 08, 2017 /PRNewswire/ --
AAK's President and CEO, Arne Frank, is currently undergoing medical treatment that is expected to last for another two to four weeks. An additional rehabilitation period may be required before Arne Frank returns to full employment.
Against this background, AAK's Board of Directors has today decided to appoint the company's CFO, Fredrik Nilsson, as acting CEO during this period.
For further information, please contact:
Chairman of the Board of Directors
Chairman of the Nomination Committee
This information is information that AAK AB (publ.) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 08:30 a.m. CET on May 8, 2017.
AAK is a leading provider of value-adding vegetable oils & fats. Our expertise in lipid technology within foods and special nutrition applications, our wide range of raw materials and our broad process capabilities enable us to develop innovative and value-adding solutions across many industries – Chocolate & Confectionery, Bakery, Dairy, Special Nutrition, Foodservice, Personal Care, and more. AAK's proven expertise is based on more than 140 years of experience within oils & fats. Our unique co-development approach brings our customers' skills and know-how together with our own capabilities and mindset for lasting results. Listed on the NASDAQ OMX Stockholm and with our headquarters in Malmö, Sweden, AAK has 20 different production facilities, sales offices in more than 25 countries and more than 3,000 employees. We are AAK – The Co-Development Company.
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
Press release (PDF)
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/aaks-ceo-undergoing-medical-treatment-300452942.html